Y-Intercept (HK)’s Disc Medicine IRON Stock Holding History

Y-Intercept (HK)’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.97M	Buy	+26,888	New	+$1.85M	0.04%	719
2026 Q1	–	Sell	-11,359	Closed	-$902K	–	1795
2025 Q4	$902K	Sell	11,359 -31,928	-74%	-$2.7M	0.02%	1017
2025 Q3	$2.86M	Buy	43,287 +33,905	+361%	+$2.02M	0.07%	424
2025 Q2	$497K	Buy	+9,382	New	+$441K	0.01%	1204
2024 Q4	–	Sell	-9,057	Closed	-$445K	–	1416
2024 Q3	$445K	Buy	+9,057	New	+$425K	0.03%	835
2024 Q1	–	Sell	-9,844	Closed	-$569K	–	1560
2023 Q4	$569K	Buy	+9,844	New	+$504K	0.05%	539

Other funds holding IRON

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

Eleva Capital Paris, France $343M AUM

AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Y-Intercept (HK)'s IRON Position: Q2 2026 in Review

Y-Intercept (HK) opened a new position in Disc Medicine (IRON) in Q2 2026: 26,888 shares worth $1.97M. The stake represents 0.04% of the portfolio and ranks #719 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in IRON as recently as Q4 2025.

Y-Intercept (HK) first reported a position in IRON in Q4 2023 and has held it in 6 quarters since. The position peaked at $2.86M in Q3 2025. 23 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

Y-Intercept (HK) held 26,888 shares of Disc Medicine worth $1.97M as of Q2 2026.
Disc Medicine was a new Y-Intercept (HK) position in Q2 2026.
Disc Medicine made up 0.04% of Y-Intercept (HK)'s portfolio in Q2 2026, its #719 holding.
Y-Intercept (HK) first reported a position in Disc Medicine in Q4 2023 and has held it in 6 quarters since.
Y-Intercept (HK)'s Disc Medicine position peaked at $2.86M in Q3 2025.
23 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.